Literature DB >> 16157917

Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies.

A Crespel1, P Genton, M Berramdane, P Coubes, C Monicard, M Baldy-Moulinier, P Gelisse.   

Abstract

Five patients with idiopathic generalized epilepsies (IGE) treated with lamotrigine (LTG) experienced exacerbation or de novo appearance of myoclonic jerks (MJ). In three patients, LTG exacerbated MJ in a dose-dependent manner with early aggravation during titration. MJ disappeared when LTG dose was decreased by 25 to 50%. In two patients, LTG exacerbated MJ in a delayed but more severe manner, with myoclonic status that only ceased after LTG withdrawal.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157917     DOI: 10.1212/01.wnl.0000174517.21383.36

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Now we know the drug of first choice--or do we?

Authors:  Jacqueline A French
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

Review 2.  Sleep-Related Epilepsy.

Authors:  Mar Carreño; Santiago Fernández
Journal:  Curr Treat Options Neurol       Date:  2016-05       Impact factor: 3.598

Review 3.  Medical management of Lennox-Gastaut syndrome.

Authors:  Aspasia Michoulas; Kevin Farrell
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 4.  Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.

Authors:  Anna Serafini; Elizabeth Gerard; Pierre Genton; Arielle Crespel; Philippe Gelisse
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

Review 5.  Epilepsy with myoclonic absences.

Authors:  Pierre Genton; Michelle Bureau
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 6.  Sodium Channel Blockers in the Treatment of Epilepsy.

Authors:  Martin J Brodie
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

Review 7.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Dean P Sarco; Blaise F D Bourgeois
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 8.  Genetic generalized epilepsies in adults - challenging assumptions and dogmas.

Authors:  Bernd J Vorderwülbecke; Britta Wandschneider; Yvonne Weber; Martin Holtkamp
Journal:  Nat Rev Neurol       Date:  2021-11-26       Impact factor: 42.937

Review 9.  Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: focus on once-daily lamotrigine.

Authors:  Linda Steinbaugh; Jerzy P Szaflarski
Journal:  Drug Des Devel Ther       Date:  2010-11-18       Impact factor: 4.162

Review 10.  Treatment of myoclonus.

Authors:  John N Caviness
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.